Clinical Trials Directory

Trials / Completed

CompletedNCT05678985

Evaluating Impact and Implementation of Choose to Move (Phase 4)

Choose to Move (Phase 4): Impact and Implementation Evaluation of a Program to Enhance Older Adult Physical Activity, Mobility and Health

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
550 (actual)
Sponsor
University of British Columbia · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Accepted

Summary

The objectives of this study are to: 1) evaluate whether Choose to Move (CTM) Phase 4 improves health outcomes in older adults who participate and 2) assess whether CTM Phase 4 is delivered as planned and what factors support or inhibit its delivery at scale. CTM Phase 4 is a 3-month, choice-based program for low active older adults being scaled-up across British Columbia (BC), Canada. The goals of CTM are to enhance physical activity, mobility and social connectedness in older adults living in BC, Canada.

Detailed description

Choose to Move (CTM) Phase 4 is a 3-month, choice-based program for low active older adults being scaled-up in phases across British Columbia (BC), Canada. Within CTM (Phase 4), trained activity coaches support older adults in two ways. First, in a one-on-one consultation, activity coaches help participants to set goals and create action plans for physical activity tailored to each person's interests and abilities. Older adults can choose to participate in individual or group-based activities. Second, activity coaches facilitate 8 group meetings with small groups of participants. Activity coaches and recreation departments across BC are trained and provided with resources to deliver CTM. Objectives: 1. To assess the impact (effectiveness) of CTM (Phase 4) delivered at scale on the physical activity, mobility, and social connectedness of older adults (Part I - Impact Evaluation) 2. To assess whether CTM (Phase 4) was implemented as planned (fidelity) and investigate factors that support or inhibit its implementation at scale (Part II - Implementation Evaluation). Study Design: The investigators use a hybrid type 2 effectiveness-implementation (Curran et al 2012) pre-post study design to evaluate CTM. The investigators use multiple methods (quantitative and qualitative) and collect data at 0 (baseline), 3 (post-intervention), 6 (3 months post-intervention), 15 (12 months post-intervention) and 27 (24 months post-intervention) months to assess impact and implementation of CTM.

Conditions

Interventions

TypeNameDescription
BEHAVIORALChoose to MoveAs described under study arm description.

Timeline

Start date
2020-09-17
Primary completion
2025-01-29
Completion
2025-01-29
First posted
2023-01-10
Last updated
2025-03-27

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT05678985. Inclusion in this directory is not an endorsement.